Response to: Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC- ain't no mountain high enough…. to keep me getting to you by Jeremic Branislav

Couñago Lorenzo, Felipe; Rodríguez de Dios, Nuria; Montemuiño, Sara; Jové Teixidó, Josep; Martín, Margarita; Calvo Crespo, Patricia; López Mata, Miriam; Thuissard Vasallo, Israel John; Sanz Rosa, David; Taboada, Begoña; Et al.

doi:0.1016/j.lungcan.2018.06.031

Home

dc.contributor.author	Couñago Lorenzo, Felipe
dc.contributor.author	Rodríguez de Dios, Nuria
dc.contributor.author	Montemuiño, Sara
dc.contributor.author	Jové Teixidó, Josep
dc.contributor.author	Martín, Margarita
dc.contributor.author	Calvo Crespo, Patricia
dc.contributor.author	López Mata, Miriam
dc.contributor.author	Thuissard Vasallo, Israel John
dc.contributor.author	Sanz Rosa, David
dc.contributor.author	Taboada, Begoña
dc.contributor.author	Et al.	spa
dc.date.accessioned	2018-12-13T13:32:04Z
dc.date.available	2018-12-13T13:32:04Z
dc.date.issued	2018
dc.identifier.citation	Couñago, F., de Dios, N. R., Montemuiño, S., Jové-Teixidó, J., Martin, M., Calvo-Crespo, P., ... & Díaz-Díaz, V. (2018). Response to: Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC-ain't no mountain high enough…. to keep me getting to you by Jeremic Branislav. Lung Cancer (Amsterdam, Netherlands), 123, 174. https://doi.org/10.1016/j.lungcan.2018.06.031	spa
dc.identifier.issn	0169-5002
dc.identifier.uri	http://hdl.handle.net/11268/7690
dc.description.abstract	We wish to thank Jeremic and colleagues for commenting on our recent article [1]. As those authors observed in their comment, our study has several limitations (all of which were described in the article) related to the retrospective design. While we appreciate the feedback provided by those authors, we would like to clarify several points raised in their letter...	spa
dc.description.sponsorship	Sin financiación	spa
dc.language.iso	eng	spa
dc.title	Response to: Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC- ain't no mountain high enough…. to keep me getting to you by Jeremic Branislav	spa
dc.type	article	spa
dc.description.impact	4.599 JCR (2018) Q1, 12/63 Respiratory System; Q2, 64/230 Oncology	spa
dc.description.impact	1.905 SJR (2018) Q1, 44/226 Cancer Research, 58/381 Oncology, 9/152 Pulmonary and Respiratory Medicine	spa
dc.description.impact	No data IDR 2018	spa
dc.identifier.doi	0.1016/j.lungcan.2018.06.031
dc.rights.accessRights	closedAccess	spa
dc.subject.uem	Cáncer	spa
dc.subject.unesco	Cáncer	spa
dc.description.filiation	UEM	spa
dc.peerreviewed	Si	spa